Norway In-vitro Toxicology Testing Market Size & Outlook
Norway in-vitro toxicology testing market, 2018-2030 (US$M)
Related Markets
Norway in-vitro toxicology testing market highlights
- The Norway in-vitro toxicology testing market generated a revenue of USD 389.9 million in 2023 and is expected to reach USD 727.9 million by 2030.
- The Norway market is expected to grow at a CAGR of 9.3% from 2024 to 2030.
- In terms of segment, pharmaceutical industry was the largest revenue generating end user in 2023.
- Diagnostics is the most lucrative end user segment registering the fastest growth during the forecast period.
In-vitro toxicology testing market data book summary
| Market revenue in 2023 | USD 389.9 million |
| Market revenue in 2030 | USD 727.9 million |
| Growth rate | 9.3% (CAGR from 2023 to 2030) |
| Largest segment | Pharmaceutical industry |
| Fastest growing segment | Diagnostics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry |
| Key market players worldwide | Charles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc |
Other key industry trends
- In terms of revenue, Norway accounted for 1.3% of the global in-vitro toxicology testing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany in-vitro toxicology testing market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 3,892.8 million by 2030.
Pharmaceutical industry was the largest segment with a revenue share of 40.55% in 2023. Horizon Databook has segmented the Norway in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
Factors such as stringent regulatory guidelines for preventing animal testing, increasing demand for toxicological testing procedures, and technological advancements for developing sophisticated & accurate toxicology testing methods are projected to drive the in-vitro toxicology testing market in the country.
Moreover, several investments from market players owing to growing biotechnology and pharmaceutical sectors in the country have propelled the market growth to a significant extent. For instance, in June 2022 FUJIFILM Corporation announced an investment of USD 1.6 billion to expand and enhance its global offering of cell culture manufacturing services.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In-vitro Toxicology Testing Market Scope
In-vitro Toxicology Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway in-vitro toxicology testing market size, by end user, 2018-2030 (US$M)
Norway In-vitro Toxicology Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
